Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 26.70% vs -1.49% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 44.69% vs 9.97% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 24.62% vs 6.93% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 37.50% vs 33.33% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Bide Pharmatech Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 6.16% vs 11.74% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 26.70% vs -1.49% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 8.43% vs 39.09% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 44.69% vs 9.97% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -0.69% vs 18.09% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 24.62% vs 6.93% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -15.38% vs -40.91% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 37.50% vs 33.33% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






